Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 2.44% vs 0.35% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -2.77% vs -37.44% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 4.22% vs -29.54% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 0.00% vs 300.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of R&G PharmaStudies Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 19.52% vs -5.18% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 2.44% vs 0.35% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 32.95% vs -52.77% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -2.77% vs -37.44% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 44.48% vs -43.07% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 4.22% vs -29.54% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.00% vs 300.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






